Unity Biotechnology, Inc.
DelistedCIK 1463361fmd_1FMJ0RG1C7HDMQHCDASM7BAV6NManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2016 to Mar 31, 2025, 34 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | 0 | 0 | 5 | 0 | 0 | 0 |
| Research and development | 14 | 37 | 59 | 71 | 67 | 38 | 37 | 20 | 13 |
| Total operating expenses | 19 | 47 | 79 | 90 | 94 | 61 | 58 | 45 | 31 |
| Operating income | (19) | (46) | (79) | (90) | (94) | (57) | (58) | (45) | (31) |
| Interest expense | – | – | – | 0 | 1 | 3 | 4 | 2 | 0 |
| Other non-operating income (expense) | – | (0) | (0) | 4 | 0 | (1) | (1) | (2) | (0) |
| Net income | (30) | (45) | (76) | (82) | (94) | (61) | (44) | (40) | (26) |